Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Anacor's phase IIb trial of AN-2728 in psoriasis reaches full enrollment

March 18, 2011

Fibrocell Science provides FDA final data from azficel-T histology study

March 18, 2011

Pluristem Therapeutics and NYU Medical Center partner to treat diabetic foot ulcers

March 16, 2011

Janssen Pharma launches Stelara in Japan for psoriasis

March 14, 2011

AstraZeneca and Galderma to develop dermatological therapies

March 9, 2011

Clinuvel receives FDA clearance for pilot phase II trial of Scenesse in vitiligo

March 3, 2011

Mochida Pharma requests Japanese approval for Beselna in solar keratoses

March 2, 2011

Sunnybrook Health Sciences and sanofi-aventis to develop vasculotide

Feb. 25, 2011

CalciMedica begins phase I trial of CM-2489 for psoriasis

Feb. 23, 2011

Corticotropin-releasing factor receptor antagonist astressin B activates hair growth in vivo

Feb. 22, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...